NUDT15 and acute lymphoblastic leukemia: Genetic variants in NUDT15, which characterize a loss or severe decrease in its function, can lead patients treated with thiopurines to an excessive activation of these drugs, causing serious adverse effects, such as hematopoietic toxicities in malignant conditions such as ALL [8].